Efficacy Study of Single Agent Trastuzumab or Lapatinib to Treat HER2-Overexpressing Breast Cancer
Clinical trial NCT00842998 · UNKNOWN
Trial details
- NCT number
- NCT00842998
- Sponsor
- Azienda Ospedaliera Ordine Mauriziano di Torino
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2011-12-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.